KR950003445A - 양자리공의 항바이러스성 단백질(pap)을 발현하는 미생물 - Google Patents
양자리공의 항바이러스성 단백질(pap)을 발현하는 미생물 Download PDFInfo
- Publication number
- KR950003445A KR950003445A KR1019930012360A KR930012360A KR950003445A KR 950003445 A KR950003445 A KR 950003445A KR 1019930012360 A KR1019930012360 A KR 1019930012360A KR 930012360 A KR930012360 A KR 930012360A KR 950003445 A KR950003445 A KR 950003445A
- Authority
- KR
- South Korea
- Prior art keywords
- antiviral protein
- pap
- vector
- microorganism
- aries
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
- A61K47/6819—Plant toxins
- A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Botany (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
본 발명은 미생물내에서 외래유전자의 발현을 가능하게 하는 벡터에 양자리공의 항바이러스성 단백질(PAP:Phytolacca antiviral protein)을 암호화하고 있는 유전자를 삽입하여 제조한 항바이러스성 단백질 유전자 발현벡터, 이 발현벡터를 미생물에 형질전환시킨 형질전환체 및 이 형질전환체를 배양함으로써 항바이러스성 단백질을 제조하는 방법에 관한 것이다.
본 발명의 벡터를 이용하여 항바이러스성 단백질을 생성하고 발현되는 형질전환 미생물을 제조함으로써, 생물학적 활성을 지닌 항바이러스성 단백질을 보다 용이하게 생산할 수 있음은 물론, AIDS등 치료에 사용되는 면역결합체 등의 제조에 사용할 수 있을 것이다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제 1 도는 본 발명의 PAP를 발현하는 벡터 pMJ13를 제조하기 위한 전략을 나타내는 모식도이다. 제 2 도는 본 발명의 pMJ12를 나타내는 전기영동 사진이다. 제 3 도는 pMJ12로 형질전환된 대장균 HB101의 생장곡선을 나타낸 그래프이다.
Claims (5)
- 양자리공의 항바이러스성 단백질 (PAP: Phytolacca antiviral protein)유전자를 포함하는 재조합 벡터 pMJ12(KCCM 10037).
- 제 1 항의 재조합 벡터로 형절전환된 미생물.
- 제 1 항의 재조합 벡터로 형절전환된 대장균(E. coli) HB101(KCCM 10037).
- 제 1 항의 재조합 벡터로 형절전환된 대장균 HB101을 배양하여 분리, 정제함으로써, 양자리공의 재조합 항바이러스성 단백질을 제조하는 방법.
- 제 4 항의 방법에 의해 제조된 항바이러스성 단백질 재조합 PAP.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019930012360A KR960015747B1 (ko) | 1993-07-02 | 1993-07-02 | 양자리공의 항바이러스성 단백질(pap)을 발현하는 미생물 |
CA002102859A CA2102859C (en) | 1993-07-02 | 1993-11-10 | Expression vector for phytolacca antiviral protein |
AU50642/93A AU662844B2 (en) | 1993-07-02 | 1993-11-11 | A novel expression vector for phytolacca antiviral protein |
EP93119118A EP0637591A3 (en) | 1993-07-02 | 1993-11-26 | New expression vector for the phytolacca antiviral protein. |
JP5337947A JP2531930B2 (ja) | 1993-07-02 | 1993-12-28 | アメリカヤマゴボウの抗ウィルス性タンパク質を発現する微生物 |
US08/342,786 US5648234A (en) | 1993-07-02 | 1994-11-21 | Expression vector for Phytolacca antiviral protein |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019930012360A KR960015747B1 (ko) | 1993-07-02 | 1993-07-02 | 양자리공의 항바이러스성 단백질(pap)을 발현하는 미생물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR950003445A true KR950003445A (ko) | 1995-02-16 |
KR960015747B1 KR960015747B1 (ko) | 1996-11-20 |
Family
ID=19358572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019930012360A KR960015747B1 (ko) | 1993-07-02 | 1993-07-02 | 양자리공의 항바이러스성 단백질(pap)을 발현하는 미생물 |
Country Status (6)
Country | Link |
---|---|
US (1) | US5648234A (ko) |
EP (1) | EP0637591A3 (ko) |
JP (1) | JP2531930B2 (ko) |
KR (1) | KR960015747B1 (ko) |
AU (1) | AU662844B2 (ko) |
CA (1) | CA2102859C (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110016470A (zh) * | 2019-05-09 | 2019-07-16 | 江苏森瑞谱生物制药有限公司 | 一种从商陆中提取纯化商陆抗病毒蛋白的方法 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR970001565B1 (ko) * | 1993-08-28 | 1997-02-11 | 장기하 | 섬자리공 항바이러스성 단백질(pip) 유전자 및 이를 발현하는 미생물 |
KR970007864B1 (ko) * | 1994-07-21 | 1997-05-17 | 진로 주식회사 | 섬자리공의 항바이러스성 단백질(pip)을 발현하는 식물체의 제조방법 |
KR970074934A (ko) * | 1996-05-22 | 1997-12-10 | 문상목 | 섬자리공 항바이러스성 단백질의 신규한 유전자 및 그를 발현하는 재조합 미생물 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57106625A (en) * | 1980-12-22 | 1982-07-02 | Teijin Ltd | Cytotoxic protein complex and its preparation |
US5101025A (en) * | 1989-04-04 | 1992-03-31 | Genelabs Incorporated | Recombinant trichosanthin and coding sequence |
DE69131253T2 (de) * | 1990-10-09 | 2000-02-24 | New York University New York | Zur behandlung von tumoren und hiv-infektionen nützliches pflanzliches protein |
US5376546A (en) * | 1991-11-04 | 1994-12-27 | Xoma Corporation | Analogs of ribosome-inactivating proteins |
KR970001565B1 (ko) * | 1993-08-28 | 1997-02-11 | 장기하 | 섬자리공 항바이러스성 단백질(pip) 유전자 및 이를 발현하는 미생물 |
-
1993
- 1993-07-02 KR KR1019930012360A patent/KR960015747B1/ko not_active IP Right Cessation
- 1993-11-10 CA CA002102859A patent/CA2102859C/en not_active Expired - Fee Related
- 1993-11-11 AU AU50642/93A patent/AU662844B2/en not_active Ceased
- 1993-11-26 EP EP93119118A patent/EP0637591A3/en not_active Withdrawn
- 1993-12-28 JP JP5337947A patent/JP2531930B2/ja not_active Expired - Lifetime
-
1994
- 1994-11-21 US US08/342,786 patent/US5648234A/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110016470A (zh) * | 2019-05-09 | 2019-07-16 | 江苏森瑞谱生物制药有限公司 | 一种从商陆中提取纯化商陆抗病毒蛋白的方法 |
Also Published As
Publication number | Publication date |
---|---|
AU662844B2 (en) | 1995-09-14 |
AU5064293A (en) | 1995-01-19 |
KR960015747B1 (ko) | 1996-11-20 |
EP0637591A3 (en) | 1995-05-24 |
CA2102859C (en) | 1998-04-28 |
JP2531930B2 (ja) | 1996-09-04 |
EP0637591A2 (en) | 1995-02-08 |
US5648234A (en) | 1997-07-15 |
JPH0767660A (ja) | 1995-03-14 |
CA2102859A1 (en) | 1995-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE127694T1 (de) | Lebende impfstoffe. | |
KR930006160A (ko) | L-트레오닌의 제조방법 | |
KR930010185A (ko) | L-이소로이신(l-isoleucine)의 제조법 | |
DE69636878D1 (de) | Zirkuläres DNA Molekül mit einem abhängigen Replikationsursprung, seine Herstellungsverfahren und seine Verwendung in der Gentherapie | |
ATE193727T1 (de) | Verfahren zur herstellung von peroxidasen in einem aspergillusstamm | |
KR870006188A (ko) | 과립구 대식세포 콜로니 촉진 인자(gm-csf) 단백질의 제조방법 | |
KR950003445A (ko) | 양자리공의 항바이러스성 단백질(pap)을 발현하는 미생물 | |
KR930700665A (ko) | 옥살레이트 옥시다제 코딩 유전자의 도입에 의한 스클레로티니아 스클레로티오룸(Scerotinia sclerotiorum)공격 저항성 식물의 생성 방법 | |
ATA901196A (de) | Verwendung von aktiviertem protein c zur herstellung einer pharmazeutischen präparation | |
DE3681940D1 (de) | Reagenz zur bestimmung durch haemagglutination von antikoerpern gegen bakterien-toxine, verfahren zu ihrer herstellung und verwendung. | |
KR900008047A (ko) | L-트레오닌의 제조방법 | |
ATE196088T1 (de) | Verfahren zur gewinnnung von zellkulturen mit erhöhtem gehalt an körpereigenen zytokinen | |
KR950005991A (ko) | 섬자리공 항바이러스성 단백질(pip) 유전자 및 이를 발현하는 미생물 | |
AU695849B2 (en) | Contact lenses with hydrophilic crosslinkers | |
KR910016933A (ko) | L-트리오닌의 제조방법 | |
KR840000643A (ko) | 구아노신의 제조법 | |
DK0503546T3 (da) | Fremgangsmåde til biologisk rensning af vand | |
KR920012425A (ko) | 동물세포 배양용 고농도 배지 및 배양공정 | |
DE69316352D1 (de) | Eine methode zur einschränkung des uberlebens gentechnologisch hergestellter mikroorganismen in ihrer umgebung | |
DE69606959D1 (de) | Verfahren zur Herstellung von Plättchen-Faktor-4 | |
EP0765935A3 (en) | Growth environment assembly and method of use thereof | |
EP0765933A3 (en) | Growth environment assembly and method of use thereof | |
WO2002010370A1 (fr) | Procede de production d'une proteine recombinee | |
EP0214564A3 (de) | Verfahren zur Herstellung von Proteinen bestimmter N-terminaler Struktur mit Hilfe von Prokaryonten | |
EP0765934A3 (en) | Growth environment assembly and method for use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |